These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7018457)

  • 41. [Original serological test for the detection of anticomplex antibodies responsible for the formation of ABO incompatibility in pregnancy in women and in the mothers].
    Skrzypulec Z
    Ginekol Pol; 1969 Feb; 40(2):167-70. PubMed ID: 5767870
    [No Abstract]   [Full Text] [Related]  

  • 42. [Sensitization caused by rare antigens and hemolytic disease of the newborn].
    Moretti M; Bovi I; Bevilacqua G
    Minerva Pediatr; 1968 Sep; 20(37):1923-5. PubMed ID: 5754687
    [No Abstract]   [Full Text] [Related]  

  • 43. [Hemolytic disease caused by ABO factors. Statistical and therapeutic considerations on a 2-year period].
    Vignolo Lutati U; Gavinelli R
    Minerva Pediatr; 1971 Aug; 23(33):1383-7. PubMed ID: 5166215
    [No Abstract]   [Full Text] [Related]  

  • 44. ABO hemolytic disease of the newborn as a selection mechanism at the ABO locus.
    Sever LE
    Am J Phys Anthropol; 1969 Sep; 31(2):177-86. PubMed ID: 5388668
    [No Abstract]   [Full Text] [Related]  

  • 45. Recurrence rate of ABO hemolytic disease of the newborn.
    Katz MA; Kanto WP; Korotkin JH
    Obstet Gynecol; 1982 May; 59(5):611-4. PubMed ID: 7070734
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Our experience in the diagnosis and clinical course of hemolytic disease of the newborn].
    Novachev D
    Akush Ginekol (Sofiia); 1967; 6(1):15-21. PubMed ID: 5601850
    [No Abstract]   [Full Text] [Related]  

  • 47. [Difficulties in the serological diagnosis of ABO erythroblastosis].
    Reichert K; Sachs V
    Zentralbl Gynakol; 1966 Oct; 88(40):1345-8. PubMed ID: 5995415
    [No Abstract]   [Full Text] [Related]  

  • 48. [Behavior of erythrocytic acetylcholinesterase activity in the hemolytic disease of the newborn due to ABO incompatibility in relation to erythrocyte age].
    Gerlini G; Ottaviano S; Sbraccia C; Carapella E; Bonanni V
    Riv Clin Pediatr; 1968; 81(5):742-5. PubMed ID: 5754265
    [No Abstract]   [Full Text] [Related]  

  • 49. [Hemolytic disease of the newborn due to Kell sensitization].
    Beller U; Hochner-Celnikier D; Ron M; Palti Z; Beyth Y
    Harefuah; 1981 Jul; 101(1-2):14-5. PubMed ID: 7319365
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinical study of early interventions for ABO hemolytic disease of the newborn].
    Huang WM; Chen HW; Li N; Yang M; Jiao PY
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1350-1, 1355. PubMed ID: 16982453
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A case of hemolytic disease of the newborn caused by anti-M antibodies].
    Burenkova LV
    Pediatriia; 1969 May; 48(5):88-9. PubMed ID: 5817806
    [No Abstract]   [Full Text] [Related]  

  • 52. Haemolytic disease of the newborn due to a new red cell antigen 'Pollio'.
    McClelland WM; McLaughlin KG; Poole J; Giles CM
    Clin Lab Haematol; 1982; 4(2):201-3. PubMed ID: 7116800
    [No Abstract]   [Full Text] [Related]  

  • 53. Hemolytic disease of the newborn due to anti-c.
    Saenz RB
    J Tenn Med Assoc; 1993 Jan; 86(1):9-11. PubMed ID: 8455385
    [No Abstract]   [Full Text] [Related]  

  • 54. ABO hemolytic disease caused by a cross-reacting antibody. Report of a case.
    Hughes BE
    Am J Clin Pathol; 1965 Dec; 44(6):665-6. PubMed ID: 5891841
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [124 cases of hemolytic diseases in newborn infants other than ABO and Rhesus D observed in the Blood Transfusion Center of Lyon between 1970 and 1982].
    Monestier M; Rigal D; Meyer F; Juron-Dupraz F
    Pediatrie; 1984 Mar; 39(2):93-100. PubMed ID: 6540863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Complement is not activated in AB0-haemolytic disease of the newborn: two exceptions.
    Pujol M; Ribera A; Abella E; Natal A; Bel J; Coroleu W
    Vox Sang; 1991; 61(1):76. PubMed ID: 1949716
    [No Abstract]   [Full Text] [Related]  

  • 58. The serological specificity of the sensitising antibodies in ABO heterospecific pregnancy of the group O mother.
    Voak D
    Vox Sang; 1968; 14(4):271-81. PubMed ID: 5690209
    [No Abstract]   [Full Text] [Related]  

  • 59. [Immunization mechanisms in serological conflicts of ABO factors. II. The 2d immunization mechanism in ABO conflict].
    Skrzypulec Z
    Ginekol Pol; 1969 Jul; 40(7):789-96. PubMed ID: 5387536
    [No Abstract]   [Full Text] [Related]  

  • 60. Transfusion reaction due to unrecognized ABO hemolytic disease of the newborn infant.
    Falterman CG; Richardson CJ
    J Pediatr; 1980 Nov; 97(5):812-4. PubMed ID: 7431177
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.